emodepside: Clinical Trials

9 trials of emodepside, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 2 not yet recruiting, 1 unknown. 5 Phase 2, 2 Phase 1, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Not yet recruiting 1, Unknown 1
Phase 12Completed 2
Phase 32Completed 1, Not yet recruiting 1

Follow emodepside: new trials by email Literature Review of emodepside trials Research Report on emodepside

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of a Single Dose of Emodepside Compared to a Single Dose of Albendazole in Adolescents and Adults Infected With Trichuris Incognita
Emodepside, Albendazole 400 mg - Trichuris Infection
Phase 2Not yet recruitingJennifer Keiser1002026-11-152026-08-14
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
emodepside (BAY 44-4400), Mebendazole 100 MG, similar placebo to mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 3Not yet recruitingSwiss Tropical & Public Health Institute3152026-11-062026-08-14
Efficacy and Safety of Emodepside in Participants With Soil-transmitted Helminth Infections
emodepside (BAY 44-4400), matching placebo of emodepside, Mebendazole - Trichuris Trichiura; Infection, Hookworm Infection
Phase 3CompletedSwiss Tropical & Public Health Institute3152025-11-252026-10-08
Efficacy and Safety of Emodepside in Adults Infected With Strongyloidiasis Stercoralis
Emodepside - Strongyloides Stercoralis Infection, Strongyloidiasis
Phase 2CompletedSwiss Tropical & Public Health Institute2022024-05-202024-11-20
Efficacy and Safety of Emodepside in Adolescents and Adults Infected With Hookworm
Emodepside, Albendazole 400mg - Hookworm Infections
Phase 2CompletedJennifer Keiser3202022-09-162023-06-15
Emodepside Phase II Trial for Treatment of Onchocerciasis
emodepside, matching placebo of emodepside, ivermectin - Onchocerciasis
Phase 2UnknownDrugs for Neglected Diseases5782021-08-302024-03-05
Efficacy and Safety of Emodepside in Adults Infected With Trichuris Trichiura and Hookworm
Emodepside - Trichuris Trichiura; Infection, Hookworm Infections
Phase 2CompletedJennifer Keiser4422021-08-022022-05-27
Relative Bioavailability Study of Emodepside IR-tablets and Solution
Emodepside (BAY 44-4400) - Filariasis
Phase 1CompletedDrugs for Neglected Diseases772017-10-262020-03-09
First in Man Clinical Trial of Emodepside (BAY 44-4400)
emodepside (BAY 44-4400), placebo - Healthy Volunteers
Phase 1CompletedDrugs for Neglected Diseases792015-12-012020-04-13

Conditions studied

Ancylostomiasis (4)  ·  Hookworm Infections (4)  ·  Trichuriasis (4)  ·  Filariasis (3)  ·  Enterobiasis (2)  ·  Helminthiasis (2)  ·  Neglected Diseases (2)  ·  Nematode Infections (2)  ·  Onchocerciasis (2)  ·  Parasitic Diseases (2)  ·  Skin Diseases (2)  ·  Skin Diseases, Infectious (2)  ·  Skin Diseases, Parasitic (2)  ·  Onchocerciasis, Ocular (1)  ·  Secernentea Infections (1)

Sponsors

Drugs for Neglected Diseases (3)  ·  Jennifer Keiser (3)  ·  Swiss Tropical & Public Health Institute (3)

Countries

Tanzania (3)  ·  United Kingdom (2)  ·  Democratic Republic of the Congo (1)  ·  Ghana (1)  ·  Laos (1)  ·  Philippines (1)

Top investigators

Jennifer Keiser, Professor (2)  ·  Frederic Monnot (1)  ·  Jeremy Dennison (1)  ·  Malcolm Boyce, MD, BSc (1)  ·  Said Mohammed Ali, MSc (1)

Results publications

PMID 37195942, PMID 37195949, PMID 39153818, PMID 40580974, PMID 41121745

NIH funding

2015 (1), 2017 (1)